authors
- Price, D
- Musgrave, S
- Wilson, E
- Sims, E
- Shepstone, L
- Blyth, A
- Murdoch, J
- Mugford, M
- Juniper, Elizabeth
- Ayres, J
- Wolfe, S
- Freeman, D
- Lipp, A
- Gilbert, R
- Harvey, I
A pragmatic single-blind randomised controlled trial and economic evaluation of the use of leukotriene receptor antagonists in primary care at steps 2 and 3 of the national asthma guidelines (ELEVATE study).
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
publication date
- May 2011
has subject area
- 0806 Information Systems (FoR)
- 0807 Library and Information Studies (FoR)
- 1117 Public Health and Health Services (FoR)
- Adolescent (MeSH)
- Adrenergic beta-2 Receptor Agonists (MeSH)
- Adult (MeSH)
- Aged (MeSH)
- Aged, 80 and over (MeSH)
- Anti-Asthmatic Agents (MeSH)
- Asthma (MeSH)
- Child (MeSH)
- Confidence Intervals (MeSH)
- Cost-Benefit Analysis (MeSH)
- Disease Progression (MeSH)
- Female (MeSH)
- Health Policy & Services (Science Metrix)
- Health Status Indicators (MeSH)
- Humans (MeSH)
- Leukotriene Antagonists (MeSH)
- Male (MeSH)
- Middle Aged (MeSH)
- Practice Guidelines as Topic (MeSH)
- Primary Health Care (MeSH)
- Psychometrics (MeSH)
- Quality of Life (MeSH)
- Quality-Adjusted Life Years (MeSH)
- Single-Blind Method (MeSH)
- Surveys and Questionnaires (MeSH)
- Time Factors (MeSH)
- Treatment Outcome (MeSH)
- United Kingdom (MeSH)
- Young Adult (MeSH)
published in
- Health Technology Assessment Journal